Page last updated: 2024-08-18

pyrroles and Symptom Cluster

pyrroles has been researched along with Symptom Cluster in 47 studies

Research

Studies (47)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (6.38)	18.7374
1990's	0 (0.00)	18.2507
2000's	36 (76.60)	29.6817
2010's	7 (14.89)	24.3611
2020's	1 (2.13)	2.80

Authors

Authors	Studies
Ayers, GD; Cirici, BX; Cross, NCP; Dezern, AE; Elena, C; Fenaux, P; Geissler, K; Gerds, AT; Germing, U; Itzykson, R; Kiladjian, JJ; Kishtagari, A; Komrokji, RS; Luebbert, M; Mendler, JH; Mesa, RA; Montalban-Bravo, G; Moyo, TK; Nazha, A; Onida, F; Padron, E; Patnaik, MM; Pfeilstöecker, M; Platzbecker, U; Pleyer, L; Santini, V; Sanz, GF; Savona, MR; Seegmiller, AC; Solary, E; Steensma, DP; Tibes, R; Valent, P; van de Loosdrecht, AA; Wiseman, DH; Zhang, J	1
Arlot-Bonnemains, Y; Belaud-Rotureau, MA; Dolley-Hitze, T; Goujon, JM; Jouan, F; Laguerre, B; Lorcy, N; Rioux-Leclercq, N; Verhoest, G; Vigneau, C	1
Balek, L; Buchtova, M; Dosedelova, H; Gudernova, I; Jelinkova, I; Kozubik, A; Krejci, P; Kunova, M; Pivnicka, J; Roubalova, L; Vesela, I	1
Ito, T; Jensen, RT; Lee, L	1
Humphreys, BD; Obhrai, JS; Patel, TV	1
Banerjee, S; Blazing, MA; Braunwald, E; Brilakis, ES; Califf, RM; Cannon, CP; de Lemos, JA; Morrow, DA; Murphy, SA; Sabatine, MS; Wiviott, SD	1
Behnam, SE; Fife, DJ; Linden, KG; Wu, JJ	1
Lipworth, AD; Robert, C; Zhu, AX	1
Dougu, N; Nukui, T; Taguchi, Y; Takashima, S; Tanaka, K; Toyoda, S	1
Bednaríková, D; Kocák, I	1
Bar-Or, A; Calabresi, PA; Cohen, JA; Cross, A; Ding, L; Goodman, A; Iklé, D; Kachuck, N; Kita, M; Kopetskie, H; Mass, M; Miller, A; Mokhtarani, M; Murphy, S; Pelletier, D; Preiningerova, J; Racke, M; Rosenberg, E; Schwid, S; Spencer, C; Stüve, O; Vollmer, T; Waubant, E; Weinstock-Guttman, B; Zamvil, SS	1
Duffy, SJ; Gokce, N; Holbrook, M; Kahn, D; Keaney, JF; Palmisano, J; Thomas, S; Tomasian, D; Vita, JA	1
Böhm, M; Fries, R	1
Bossaller, C; Gitt, AK; Heer, T; Juenger, C; Limbourg, P; Meisenzahl, C; Schiele, R; Senges, J; Wienbergen, H	1
Correia, LC; D'Oliveira, A; Esteves, JP; Lima, JC; Magalhães, LP; Passos, LC; Rocha, MS; Spósito, AC	1
Averkov, OV; Deev, AD; Gratsianskiĭ, NA; Pokrovskaia, EV; Slavina, NN; Vaulin, NA	1
Ganz, P; Kinlay, S; Leslie, SJ; Libby, P; Olsson, AG; Rifai, N; Sasiela, WJ; Schwartz, GG; Szarek, M	1
Arikian, S; Ganz, P; Schwartz, GG; Waters, D	1
Casciano, R; Olsson, A; Stern, L; Svangren, P	1
Lange, AP; Szucs, TD	1
von Schacky, C	1
McGowan, MP	1
Cannon, CP; Ray, KK	1
Casciano, R; Gómez-Gerique, JA; Rejas, J; Stern, L	1
Schwartz, GG	1
Badaracco, R; Brizuela, M; Cialzeta, JR; Doval, H; Farías, EF; Franciosi, V; Macin, SM; Medina, F; Perna, ER; Tajer, C	1
Braunwald, E; Cairns, R; Cannon, CP; Jackson, G; McCabe, CH; Ray, KK; Sacks, FM; Tonkin, AM	1
Braunwald, E; Cannon, CP; Morrow, DA; Pfeffer, MA; Ray, KK; Wiviott, SD	1
Braunwald, E; Cairns, R; Cannon, CP; Gibson, CM; Kirtane, AJ; McCabe, CH; Morrow, DA; Ray, KK; Ridker, PM; Rifai, N; Skene, AM	1
Amyot, R; Arnold, M; Bonafede, N; Cannon, CP; Dupuis, J; Lonn, E; Ricci, J; Rouleau, JL; Roux, R; Tardif, JC; Title, LM; Woo, A	1
Fonarow, GC	1
Qi, SS; Shen, XQ; Zeng, GF; Zhou, HN; Zhou, SH; Zhou, T	1
Braunwald, E; Cannon, CP; McCabe, CH; Morrow, DA; Murphy, SA; O'Donoghue, M; Sabatine, MS	1
Braunwald, E; Cannon, CP; Jarolim, P; McCabe, CH; Morrow, DA; Ray, KK; Sabatine, MS; Scirica, BM; Shui, A	1
Braunwald, E; Giugliano, RP	1
Daida, H; Hiro, T; Kimura, T; Matsuzaki, M; Miyauchi, K; Morimoto, T; Nakagawa, Y; Ozaki, Y; Yamagishi, M	1
Alhan, CC; Avkaroğullari, M; Cayli, M; Demir, M; Demirtaş, M; Dönmez, Y; Inal, T; Kanadaşi, M; Koç, M; San, M; Usal, A	1
Chang, JW; Hong, HS; Kuo, TT; Tsai, KY; Yang, CH	1
Chyrchel, M; Dubiel, JS; Dudek, D; Dziewierz, A; Legutko, J; Rakowski, T; Rzeszutko, L	1
Jamieson, MJ; Luo, D; Olsson, AG; Schwartz, GG; Szarek, M	1
Colonna, G; Di Sciascio, G; Fischetti, D; Miglionico, M; Montinaro, A; Pasceri, V; Patti, G; Sardella, G	1
Bellido, L; Cruz, JJ; Martín, G	1
De Angelis, S; De Lorenzo, A; Di Daniele, N; Di Renzo, L; Miani, N; Noce, A; Tozzo, C	1
Grenier, A; Meister, A; New, MI; Rifkind, AB; Sassa, S; Starkman, H; Steinherz, PG; Stoner, E; Wellner, D; Wellner, VP	1
Acevedo, M; Francis, G; Lauer, MS; Sprecher, DL	1
Sydor, A	1
Heleniak, EP; Lamola, SW	1

Reviews

8 review(s) available for pyrroles and Symptom Cluster

Article	Year
Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:16 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Everolimus; Humans; Indoles; Molecular Targeted Therapy; Neuroendocrine Tumors; Octreotide; Pyrroles; Somatostatin; Sunitinib; Syndrome; Treatment Outcome	2016
Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib. Oncology, 2009, Volume: 77, Issue:5 Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Erythema; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Niacinamide; Paresthesia; Phenylurea Compounds; Prognosis; Pyridines; Pyrroles; Risk Factors; Sorafenib; Sunitinib; Syndrome	2009
[Hand-foot syndrome after administration of tyrosinkinase inhibitors]. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2010, Volume: 23, Issue:5 Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib; Syndrome	2010
[Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure]. Medizinische Klinik (Munich, Germany : 1983), 2003, Jun-15, Volume: 98, Issue:6 Topics: Abciximab; Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Antibodies, Monoclonal; Anticholesteremic Agents; Arrhythmias, Cardiac; Aspirin; Atorvastatin; Clopidogrel; Defibrillators, Implantable; Double-Blind Method; Fibrinolytic Agents; Heart Failure; Heart Septal Defects, Atrial; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic; Regeneration; Risk Factors; Syndrome; Ticlopidine; Time Factors; Tirofiban; Tyrosine	2003
Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology. Current opinion in lipidology, 2004, Volume: 15, Issue:6 Topics: Acute Disease; Animals; Atorvastatin; Cholesterol; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Endothelial Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin; Pyrroles; Syndrome; T-Lymphocytes	2004
In-hospital initiation of statin therapy in acute coronary syndromes: maximizing the early and long-term benefits. Chest, 2005, Volume: 128, Issue:5 Topics: Angina, Unstable; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Myocardial Ischemia; Pravastatin; Pyrroles; Syndrome; Treatment Outcome	2005
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. Journal of the American College of Cardiology, 2006, Jun-06, Volume: 47, Issue:11 Topics: Acute Disease; Atorvastatin; Cardiac Output, Low; Coronary Disease; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Natriuretic Peptide, Brain; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Risk Assessment; Syndrome	2006
The year in non-ST-segment elevation acute coronary syndromes. Journal of the American College of Cardiology, 2006, Jul-18, Volume: 48, Issue:2 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Atorvastatin; Biomarkers; Clopidogrel; Coronary Vessels; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Multivariate Analysis; Myocardial Infarction; Platelet Aggregation Inhibitors; Pravastatin; Prognosis; Pyrroles; Risk Assessment; Stents; Syndrome; Thrombolytic Therapy; Ticlopidine	2006

Trials

17 trial(s) available for pyrroles and Symptom Cluster

Article	Year
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes. BMC cancer, 2022, Sep-24, Volume: 22, Issue:1 Topics: Acetonitriles; Cytidine Deaminase; Decitabine; DNA; Humans; Methyltransferases; Myelodysplastic-Myeloproliferative Diseases; Prospective Studies; Pyrazoles; Pyrimidines; Pyrroles; Quality of Life; Syndrome	2022
Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials). The American journal of cardiology, 2008, Sep-01, Volume: 102, Issue:5 Topics: Atorvastatin; Coronary Artery Bypass; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Care; Pravastatin; Pyrroles; Retrospective Studies; Simvastatin; Syndrome; Thrombolytic Therapy; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2008
Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. Neurology, 2012, Apr-10, Volume: 78, Issue:15 Topics: Adult; Anticholesteremic Agents; Atorvastatin; Brain; Canada; Confounding Factors, Epidemiologic; Contrast Media; Double-Blind Method; Female; Gadolinium; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Middle Aged; Odds Ratio; Pyrroles; Research Design; Syndrome; Treatment Outcome; United States	2012
Effect of atorvastatin on endothelium-dependent vasodilation in patients with coronary artery disease. The American journal of cardiology, 2003, Apr-01, Volume: 91, Issue:7 Topics: Aged; Atorvastatin; Blood Flow Velocity; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Middle Aged; Muscle, Smooth, Vascular; Nitroglycerin; Pyrroles; Syndrome; Time Factors; Treatment Outcome; Vasodilation; Vasodilator Agents	2003
Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction. The American journal of cardiology, 2003, Aug-01, Volume: 92, Issue:3 Topics: Aged; Angina, Unstable; Anti-Inflammatory Agents; Anticholesteremic Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pyrroles; Syndrome; Treatment Outcome	2003
[Non ST elevation acute coronary syndrome: early use of pravastatin or atorvastatin is associated with divergent changes of parameters of hemostasis]. Kardiologiia, 2003, Volume: 43, Issue:6 Topics: Acute Disease; Adult; Aged; Anticholesteremic Agents; Atorvastatin; Coronary Disease; Electrocardiography; Female; Heptanoic Acids; Homeostasis; Humans; Male; Middle Aged; Pravastatin; Pyrroles; Syndrome; Time Factors	2003
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation, 2003, Sep-30, Volume: 108, Issue:13 Topics: Acute Disease; Aged; Angina, Unstable; Apolipoproteins; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Pyrroles; Serum Amyloid A Protein; Syndrome; Troponin	2003
There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients. Circulation, 2004, Oct-19, Volume: 110, Issue:16 Topics: Acute Disease; Atorvastatin; Coronary Disease; Disease-Free Survival; Double-Blind Method; Heart Arrest; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Life Tables; Myocardial Infarction; Myocardial Ischemia; Pyrroles; Stroke; Substance Withdrawal Syndrome; Syndrome; Withholding Treatment	2004
Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study. American heart journal, 2005, Volume: 149, Issue:3 Topics: Acute Disease; Acute-Phase Proteins; Anti-Inflammatory Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Double-Blind Method; Drug Administration Schedule; Female; Guidelines as Topic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Male; Middle Aged; Prospective Studies; Pyrroles; Secondary Prevention; Syndrome	2005
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. Journal of the American College of Cardiology, 2005, Oct-18, Volume: 46, Issue:8 Topics: Acute Disease; Angina, Unstable; Atorvastatin; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Syndrome; Time Factors	2005
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. Journal of the American College of Cardiology, 2005, Oct-18, Volume: 46, Issue:8 Topics: Acute Disease; Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cross-Sectional Studies; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Pravastatin; Pyrroles; Risk Factors; Syndrome	2005
Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial). The American journal of cardiology, 2005, Nov-01, Volume: 96, Issue:9 Topics: Acute Disease; Anticholesteremic Agents; Atorvastatin; Blood Flow Velocity; Brachial Artery; Cholesterol, LDL; Coronary Disease; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Male; Middle Aged; Pravastatin; Prognosis; Pyrroles; Syndrome; Ultrasonography; Vasodilation	2005
The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome. Clinica chimica acta; international journal of clinical chemistry, 2006, Volume: 368, Issue:1-2 Topics: Acute Disease; Atorvastatin; C-Reactive Protein; Coronary Disease; Female; Heptanoic Acids; Humans; Lipid Metabolism; Middle Aged; Peroxidase; Pyrroles; Syndrome	2006
Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) Circulation, 2006, Apr-11, Volume: 113, Issue:14 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acute Disease; Atorvastatin; Coronary Disease; Double-Blind Method; Enzymes; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Phospholipases A; Phospholipases A2; Pravastatin; Pyrroles; Survival Analysis; Syndrome; Thrombolytic Therapy; Treatment Outcome	2006
Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS): rationale and design. Circulation journal : official journal of the Japanese Circulation Society, 2006, Volume: 70, Issue:12 Topics: Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Myocardial Ischemia; Pyrroles; Quinolines; Research Design; Syndrome	2006
Effects of high-dose atorvastatin in patients > or =65 years of age with acute coronary syndrome (from the myocardial ischemia reduction with aggressive cholesterol lowering [MIRACL] study). The American journal of cardiology, 2007, Mar-01, Volume: 99, Issue:5 Topics: Age Factors; Aged; Aged, 80 and over; Atorvastatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Pyrroles; Retrospective Studies; Syndrome; Treatment Outcome	2007
Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. Journal of the American College of Cardiology, 2007, Mar-27, Volume: 49, Issue:12 Topics: Acute Disease; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Atorvastatin; Coronary Disease; Double-Blind Method; Female; Heptanoic Acids; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Pyrroles; Syndrome; Time Factors; Treatment Outcome	2007

Other Studies

22 other study(ies) available for pyrroles and Symptom Cluster

Article	Year
All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Carcinoma, Renal Cell; Female; Follow-Up Studies; Humans; Hypertension; Immunohistochemistry; Indoles; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Neoplasms; Male; Middle Aged; Proteinuria; Pyrroles; Registries; Retrospective Studies; Sunitinib; Syndrome; Vascular Endothelial Growth Factor A	2014
Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes. Human molecular genetics, 2016, Jan-01, Volume: 25, Issue:1 Topics: Achondroplasia; Animals; Benzamides; Cartilage; Catalysis; Cells, Cultured; Chick Embryo; Chondrocytes; Humans; Mice; Phenylurea Compounds; Piperazines; Pyrazoles; Pyrimidines; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Signal Transduction; Syndrome	2016
The case / progressive hypertension and proteinuria on anti-angiogenic therapy. Kidney international, 2008, Volume: 74, Issue:5 Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Female; Gastrointestinal Stromal Tumors; Humans; Hypertension; Indoles; Kidney; Models, Biological; Proteinuria; Pyrroles; Sunitinib; Syndrome; Vascular Endothelial Growth Factor A	2008
Sunitinib-induced hand-foot syndrome: a new, distinct form. Clinical and experimental dermatology, 2010, Volume: 35, Issue:2 Topics: Aged; Antineoplastic Agents; Drug Eruptions; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Male; Pyrroles; Sunitinib; Syndrome	2010
[Case of branch atheromatous disease presenting capsular warning syndrome]. Rinsho shinkeigaku = Clinical neurology, 2010, Volume: 50, Issue:5 Topics: Anticoagulants; Aspirin; Atherosclerosis; Atorvastatin; Dextrans; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Heptanoic Acids; Humans; Infusions, Intravenous; Ischemic Attack, Transient; Magnetic Resonance Angiography; Male; Middle Aged; Pyrroles; Recurrence; Syndrome; Thrombolytic Therapy; Tissue Plasminogen Activator	2010
Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies. The American journal of cardiology, 2003, Aug-01, Volume: 92, Issue:3 Topics: Acute Disease; Aged; Atorvastatin; Clopidogrel; Comorbidity; Coronary Disease; Drug Interactions; Drug Utilization; Female; Germany; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Pyrroles; Registries; Stroke; Survival Analysis; Syndrome; Ticlopidine; Treatment Outcome	2003
Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The American journal of cardiology, 2003, Nov-01, Volume: 92, Issue:9 Topics: Acute Disease; Angina, Unstable; Atorvastatin; Cost-Benefit Analysis; Economics, Pharmaceutical; Health Care Costs; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Myocardial Ischemia; Pyrroles; Secondary Prevention; Syndrome	2003
A pharmacoeconomic evaluation of aggressive cholesterol lowering in Sweden. International journal of cardiology, 2004, Volume: 96, Issue:1 Topics: Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Cost-Benefit Analysis; Health Care Costs; Heptanoic Acids; Humans; Myocardial Infarction; Pyrroles; Retrospective Studies; Sweden; Syndrome; Time Factors; Treatment Outcome	2004
[Cost-effectiveness of atorvastatin in the early treatment of acute coronary syndromes in Germany based on the MIRACL study]. Medizinische Klinik (Munich, Germany : 1983), 2004, Sep-15, Volume: 99, Issue:9 Topics: Acute Disease; Adolescent; Adult; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Cost Savings; Cost-Benefit Analysis; Costs and Cost Analysis; Diagnosis-Related Groups; Double-Blind Method; Germany; Heptanoic Acids; Humans; Middle Aged; Myocardial Infarction; Patient Compliance; Placebos; Pyrroles; Randomized Controlled Trials as Topic; Retrospective Studies; Syndrome; Time Factors	2004
[Statin therapy in patients with acute coronary syndrome. "Prove-it" study]. Der Internist, 2004, Volume: 45, Issue:12 Topics: Angina, Unstable; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Proportional Hazards Models; Pyrroles; Randomized Controlled Trials as Topic; Syndrome; Treatment Outcome	2004
A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain. The European journal of health economics : HEPAC : health economics in prevention and care, 2004, Volume: 5, Issue:3 Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Coronary Artery Bypass; Cost Savings; Cost-Benefit Analysis; Diagnosis-Related Groups; Double-Blind Method; Economics, Pharmaceutical; Heptanoic Acids; Humans; Multicenter Studies as Topic; Myocardial Infarction; Placebos; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Spain; Syndrome; Time Factors; Treatment Outcome	2004
Statins in acute coronary syndromes: the sooner, the better? American heart journal, 2005, Volume: 149, Issue:3 Topics: Acute Disease; Atorvastatin; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Drug Administration Schedule; Guidelines as Topic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Secondary Prevention; Syndrome	2005
Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. Journal of the American College of Cardiology, 2005, Oct-18, Volume: 46, Issue:8 Topics: Acute Disease; Angina, Unstable; Atorvastatin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Syndrome	2005
The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol. Heart and vessels, 2006, Volume: 21, Issue:5 Topics: Acute Disease; Aged; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Follow-Up Studies; Heptanoic Acids; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Prognosis; Pyrroles; Serum Amyloid A Protein; Statistics as Topic; Syndrome; Treatment Outcome; Triglycerides	2006
Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Dec-20, Volume: 24, Issue:36 Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Dermatitis, Seborrheic; Erythema; Foot; Hand; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Sunitinib; Syndrome	2006
Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome. Kardiologia polska, 2006, Volume: 64, Issue:12 Topics: Adolescent; Adult; Aged; Angioplasty, Balloon, Coronary; Atorvastatin; Coronary Artery Bypass; Coronary Disease; Coronary Restenosis; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Premedication; Pyrroles; Retrospective Studies; Syndrome; Treatment Outcome	2006
Reversible posterior leukoencephalopathy syndrome induced by sunitinib. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Aug-10, Volume: 25, Issue:23 Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Brain; Brain Diseases; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Pyrroles; Seizures; Sunitinib; Syndrome; Treatment Outcome	2007
Anti-inflammatory effects of combined treatment with acetyl salicylic acid and atorvastatin in haemodialysis patients affected by Normal Weight Obese syndrome. Pharmacological research, 2008, Volume: 57, Issue:2 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Aspirin; Atorvastatin; Body Fat Distribution; Body Mass Index; Body Weight; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Inflammation; Kidney Failure, Chronic; Lipid Metabolism; Male; Middle Aged; Nutrition Assessment; Obesity; Prealbumin; Pyrroles; Renal Dialysis; Serum Albumin; Syndrome	2008
Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency. Pediatric research, 1984, Volume: 18, Issue:12 Topics: Erythrocytes; Fanconi Syndrome; Female; Glutathione; Heme; Humans; Infant; Liver; Liver Diseases; Mass Spectrometry; Mixed Function Oxygenases; Phosphates; Pyrroles; Rickets; Syndrome; Tyrosine	1984
Routine statin treatment after acute coronary syndromes? American heart journal, 2002, Volume: 143, Issue:6 Topics: Anticholesteremic Agents; Atorvastatin; Coronary Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Myocardial Infarction; Patient Discharge; Practice Guidelines as Topic; Pyrroles; Randomized Controlled Trials as Topic; Syndrome; Thrombolytic Therapy; Treatment Outcome	2002
[Effect of a synthetic derivative of verrucarine E and endoxan Guerin's tumor in rats]. Roczniki Akademii Medycznej im. Juliana Marchlewskiego w Bialymstoku, 1975, Volume: 20 Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Cyclophosphamide; Male; Neoplasms, Experimental; Pyrroles; Rats; Syndrome	1975
A new prostaglandin disturbance syndrome in schizophrenia: delta-6-pyroluria. Medical hypotheses, 1986, Volume: 19, Issue:4 Topics: Alprostadil; Aspartate Aminotransferases; Fatty Acid Desaturases; Fatty Acids, Essential; Humans; Insulin; Linoleic Acid; Linoleic Acids; Linoleoyl-CoA Desaturase; Mutation; Prostaglandins; Pyrroles; Schizophrenia; Syndrome	1986